UFP Technologies
UFPT
292.87
-10.00
-3.30%
UFP Technologies
US · UFPT
#2677 by market cap
Listed 1970
292.87
-10.00
-3.30%
Live - 5344 symbols - heartbeat 58s ago
· 2026-10-07 19:54
After-hours
292.87
0.00%
- Market cap
- 2.27B
- P/E (TTM)i
- 31.66
- P/Bi
- 4.91
- EPSi
- 8.75
- Div yieldi
- 0.00%
- 52W posi
- 72%
Reader sentiment
Are you bullish or bearish on UFPT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 8.31, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +19.50% YoY
Margins
- Gross margin
- 28.27%
- Operating margin
- 15.42%
- Net margin
- 11.33%
Key ratios & quality
- Enterprise valuei
- 2.39B
- PEG ratioi
- 1.78
- Altman Z-Scorei
- 8.31
PEG uses trailing P/E against the 3-year net income growth rate (17.80%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 190.46M | 198.38M | 179.37M | 206.32M | 353.79M | 400.07M | 504.42M | 602.80M |
| Gross profit | 48.31M | 53.96M | 44.68M | 51.11M | 90.26M | 112.23M | 146.69M | 170.41M |
| Selling & admin expenses | 27.65M | 29.25M | 27.49M | 29.48M | 45.80M | 50.89M | 62.22M | 77.44M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 20.65M | 24.71M | 17.19M | 21.63M | 44.46M | 61.34M | 84.48M | 92.97M |
| Pretax profit | 18.40M | 23.65M | 16.28M | 21.21M | 52.72M | 53.90M | 73.03M | 82.51M |
| Tax | 4.09M | 3.90M | 2.91M | 5.32M | 10.93M | 8.98M | 14.04M | 14.20M |
| Net profit | 14.31M | 19.75M | 13.37M | 15.89M | 41.79M | 44.92M | 58.98M | 68.31M |
| Basic EPS | 2 | 3 | 2 | 2 | 6 | 6 | 8 | 9 |
| Diluted EPS | 1.93 | 2.63 | 1.77 | 2.09 | 5.45 | 5.83 | 7.58 | 8.75 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 148.15M | 151.18M | 154.56M | 148.92M | 154.20M | 173.96M |
| Gross profit | 42.15M | 43.54M | 42.75M | 41.97M | 44.36M | 50.92M |
| Selling & admin expenses | 18.73M | 18.68M | 19.07M | 20.97M | 21.02M | 22.75M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 23.43M | 24.86M | 23.68M | 21.00M | 23.34M | 28.17M |
| Pretax profit | 20.28M | 21.63M | 21.06M | 19.54M | 21.61M | 26.43M |
| Tax | 3.10M | 4.45M | 4.68M | 1.98M | 4.11M | 5.58M |
| Net profit | 17.18M | 17.18M | 16.38M | 17.57M | 17.50M | 20.85M |
| Basic EPS | 2 | 2 | 2 | 2 | 2 | 3 |
| Diluted EPS | 2.21 | 2.21 | 2.11 | 2.25 | 2.24 | 2.68 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 55.63M | 53.25M | 71.86M | 87.32M | 116.35M | 144.63M | 194.95M | 201.00M |
| Cash & ST investments | 3.24M | 3.74M | 24.23M | 11.12M | 4.45M | 5.26M | 13.45M | 20.30M |
| Inventory | 19.58M | 18.28M | 18.64M | 33.44M | 53.54M | 70.19M | 87.54M | 86.86M |
| Total assets | 189.60M | 188.76M | 203.20M | 334.13M | 378.19M | 404.14M | 629.00M | 655.08M |
| Total current liabilities | 20.66M | 16.78M | 15.14M | 38.78M | 55.96M | 58.21M | 76.30M | 74.86M |
| Short-term debt | 2.86M | 1.15M | 1.17M | 6.24M | 6.52M | 7.22M | 16.73M | 17.54M |
| Long-term debt | 22.29M | -- | -- | 71.00M | 51.00M | 28.00M | 176.88M | 122.96M |
| Total liabilities | 49,141,000.00 | 26,767,000.00 | 26,311,000.00 | 139,686,000.00 | 140,647,000.00 | 118,045,000.00 | 286,235,000.00 | 231,200,000.00 |
| Total equity | 140.46M | 161.99M | 176.89M | 194.45M | 237.55M | 286.09M | 342.76M | 423.88M |
| Retained earnings | 111.80M | 131.55M | 144.92M | 160.81M | 202.60M | 247.52M | 306.50M | 374.81M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 205.89M | 191.39M | 197.97M | 201.00M | 224.11M | 234.89M |
| Cash & ST investments | 14.03M | 14.89M | 18.23M | 20.30M | 19.98M | 9.05M |
| Inventory | 89.84M | 85.20M | 86.15M | 86.86M | 93.98M | 100.09M |
| Total assets | 642.64M | 634.66M | 652.82M | 655.08M | 674.68M | 681.91M |
| Total current liabilities | 79.87M | 69.20M | 82.23M | 74.86M | 77.01M | 78.30M |
| Short-term debt | 16.63M | 17.22M | 17.45M | 17.54M | 17.52M | 17.24M |
| Long-term debt | 170.25M | 151.13M | 133.62M | 122.96M | 125.11M | 104.81M |
| Total liabilities | 281,968,000.00 | 249,168,000.00 | 248,908,000.00 | 231,200,000.00 | 235,809,000.00 | 219,484,000.00 |
| Total equity | 360.67M | 385.49M | 403.91M | 423.88M | 438.88M | 462.43M |
| Retained earnings | 323.69M | 340.87M | 357.25M | 374.81M | 392.31M | 413.16M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 21.32M | 31.23M | 25.04M | 14.29M | 17.74M | 41.33M | 66.59M | 91.91M |
| Depreciation & amortization | 7.83M | 8.17M | 8.27M | 8.41M | 11.89M | 11.41M | 14.72M | 19.15M |
| Free cash flow | 15.89M | 25.45M | 20.67M | 8.90M | 3.96M | 30.84M | 56.94M | 78.98M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 3.24M | 3.74M | 24.23M | 11.12M | 4.45M | 5.26M | 13.45M | 20.30M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 13.81M | 25.33M | 35.93M | 16.84M | 3.20M | 15.61M |
| Depreciation & amortization | 4.63M | 4.72M | 4.87M | 4.92M | 4.90M | 4.97M |
| Free cash flow | 10.99M | 22.47M | 32.55M | 12.97M | 1.46M | 14.45M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 14.03M | 14.89M | 18.23M | 20.30M | 19.98M | 9.05M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 10.83 | 13.06 | 7.89 | 8.56 | 19.35 | 17.16 | 18.76 | 17.82 |
| ROA %i | 8.73 | 10.44 | 6.82 | 5.91 | 11.73 | 11.48 | 11.42 | 10.64 |
| ROIC %i | 9.73 | 12.29 | 7.81 | 6.95 | 15.04 | 15.03 | 14.87 | 13.56 |
| 5-year avg ROE %i | 8.40 | 9.34 | 9.38 | 9.62 | 11.94 | 13.20 | 14.34 | 16.33 |
| EBIT margin %i | 10.36 | 12.26 | 9.12 | 10.32 | 15.68 | 14.38 | 16.08 | 15.31 |
| FCF / sales %i | 8.34 | 12.83 | 11.52 | 4.31 | 1.12 | 7.71 | 11.29 | 13.10 |
| Current ratioi | 2.69 | 3.17 | 4.75 | 2.25 | 2.08 | 2.48 | 2.56 | 2.68 |
| Quick ratioi | 1.64 | 1.95 | 3.35 | 1.30 | 1.06 | 1.22 | 1.35 | 1.45 |
| Debt / assetsi | 13.26 | 1.64 | 1.09 | 25.25 | 18.08 | 11.39 | 32.76 | 23.58 |
| LT debt / equityi | 15.87 | 1.20 | 0.59 | 40.17 | 26.04 | 13.57 | 55.23 | 32.31 |
| Interest coveragei | 14.94 | 36.08 | 197.18 | 241.97 | 20.08 | 15.79 | 10.06 | 9.42 |
| Revenue CAGR (3Y) %i | 11.11 | 10.73 | 6.66 | 2.70 | 21.27 | 30.66 | 34.72 | 19.44 |
| Net income CAGR (3Y) %i | 23.52 | 35.32 | 13.23 | 3.54 | 28.38 | 49.78 | 54.85 | 17.80 |
| FCF CAGR (3Y) %i | -- | 129.70 | 42.87 | -17.58 | -46.20 | 14.27 | 85.65 | 171.10 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 19.36 | 19.29 | 18.31 | 17.82 | 17.17 | 17.05 |
| ROA %i | 12.09 | 12.70 | 10.40 | 10.64 | 10.42 | 10.98 |
| ROIC %i | 15.93 | 16.69 | 13.55 | 13.56 | 13.13 | 13.50 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 16.11 | 16.07 | 15.61 | 15.31 | 15.20 | 15.26 |
| FCF / sales %i | 10.78 | 12.32 | 14.62 | 13.10 | 11.41 | 9.72 |
| Current ratioi | 2.58 | 2.77 | 2.41 | 2.68 | 2.91 | 3.00 |
| Quick ratioi | 1.39 | 1.47 | 1.28 | 1.45 | 1.59 | 1.61 |
| Debt / assetsi | 30.89 | 28.53 | 25.35 | 23.58 | 23.13 | 19.99 |
| LT debt / equityi | 50.44 | 42.51 | 36.66 | 32.31 | 31.57 | 25.75 |
| Interest coveragei | 8.62 | 7.67 | 8.29 | 9.42 | 10.60 | 12.41 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Products is the largest reported line at 99.16% of revenue, across 3 reported segments.
- The next-largest line, Engineering services, is a distant second at 0.58% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Products99.16%
Engineering services0.58%
Tooling and Machinery0.26%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.